U.S. flag

An official website of the United States government

NM_005902.4(SMAD3):c.741_742del (p.Phe248fs) AND Aneurysm-osteoarthritis syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 1, 2011
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000023242.4

Allele description [Variation Report for NM_005902.4(SMAD3):c.741_742del (p.Phe248fs)]

NM_005902.4(SMAD3):c.741_742del (p.Phe248fs)

Gene:
SMAD3:SMAD family member 3 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
15q22.33
Genomic location:
Preferred name:
NM_005902.4(SMAD3):c.741_742del (p.Phe248fs)
HGVS:
  • NC_000015.10:g.67181323_67181324del
  • NG_011990.1:g.120467_120468del
  • NM_001145102.2:c.426_427del
  • NM_001145103.2:c.609_610del
  • NM_001145104.2:c.156_157del
  • NM_005902.4:c.741_742delMANE SELECT
  • NP_001138574.1:p.Phe143fs
  • NP_001138575.1:p.Phe204fs
  • NP_001138576.1:p.Phe53fs
  • NP_005893.1:p.Phe248fs
  • NC_000015.9:g.67473661_67473662del
  • NM_005902.3:c.741_742del
Protein change:
F143fs
Links:
OMIM: 603109.0002; dbSNP: rs587776880
NCBI 1000 Genomes Browser:
rs587776880
Molecular consequence:
  • NM_001145102.2:c.426_427del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001145103.2:c.609_610del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001145104.2:c.156_157del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_005902.4:c.741_742del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Aneurysm-osteoarthritis syndrome
Synonyms:
ANEURYSMS-OSTEOARTHRITIS SYNDROME; LOEYS-DIETZ SYNDROME WITH OSTEOARTHRITIS; Loeys-Dietz syndrome 3; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0013426; MedGen: C3151087; Orphanet: 284984; OMIM: 613795

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000044533OMIM
no assertion criteria provided
Pathogenic
(Feb 1, 2011)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.

van de Laar IM, Oldenburg RA, Pals G, Roos-Hesselink JW, de Graaf BM, Verhagen JM, Hoedemaekers YM, Willemsen R, Severijnen LA, Venselaar H, Vriend G, Pattynama PM, Collée M, Majoor-Krakauer D, Poldermans D, Frohn-Mulder IM, Micha D, Timmermans J, Hilhorst-Hofstee Y, Bierma-Zeinstra SM, Willems PJ, Kros JM, et al.

Nat Genet. 2011 Feb;43(2):121-6. doi: 10.1038/ng.744. Epub 2011 Jan 9.

PubMed [citation]
PMID:
21217753

Details of each submission

From OMIM, SCV000044533.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 3 Dutch sibs with arterial aneurysms and dissections and early-onset osteoarthritis (LDS3; 613795), van de Laar et al. (2011) identified heterozygosity for a 2-bp deletion (741delAT) in exon 6 of the SMAD3 gene, resulting in a frameshift and a premature termination sequence at codon 309 in exon 7 that removes nearly the complete MH2 domain (Thr247ProfsTer61). The deletion, which was presumably present in their affected deceased father, was not found in their unaffected mother or in 544 Dutch control chromosomes. Analysis of patient cDNA showed very weak mutant signal compared to wildtype, and treatment of patient fibroblast cultures with cycloheximide markedly increased the mutant signal, indicating that most of the abnormal RNA was subjected to nonsense messenger RNA decay and that a truncated SMAD3 protein was barely formed.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 5, 2022